The V617F JAK2 mutation and the myeloproliferative disorders.

  • M.J. Percy
  • , Mary McMullin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)91-93
Number of pages3
JournalHematological Oncology
Volume23(3-4)
Issue number3-4
DOIs
Publication statusPublished - Sept 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this